/Companies

ReCor Medical

Palo Alto, US · 324 employees on LinkedIn · 2 known investors

Find your way into ReCor Medical

Sign up to see every warm intro you have to ReCor Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ReCor Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension. Founded in 2009 and now part of Otsuka Medical Devices, the company brings its hypertension treatment to physicians and patients worldwide.

Founders & leadership

JSJacques Seguin
Jacques SeguinFounderJacques Seguin is a cardiovascular surgeon and serial medical device entrepreneur who founded CoreValve, which was acquired by Medtronic in 2009, and ReCor Medical, which was acquired by Otsuka in 2018. He holds an MD and PhD from universities in Montpellier and Paris.
MJ
Martin J. WatersNamed on SEC filing

Board

AM
Andrew M. WeissBoard director
APAntoine Papiernik
Antoine PapiernikBoard directorChairman and Managing Partner at Sofinnova Partners
KK
Kazumichi KobayashiBoard director
FT
F. Thomas WatkinsBoard director
FL
Frank LitvackBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$22M disclosed across 1 round · 2016

▶$22MraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew M. WeissExecutive Officer, Director
  • Antoine PapiernikExecutive Officer, Director
  • F. Thomas WatkinsDirector
  • Kazumichi KobayashiDirector
  • Jacques SeguinDirector
  • Frank LitvackDirector
  • Martin J. WatersExecutive Officer
Offering amount
$22M
Amount sold
$22M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does ReCor Medical do?
Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension. Founded in 2009 and now part of Otsuka Medical Devices, the company brings its hypertension treatment to physicians and patients worldwide.
Who founded ReCor Medical?
ReCor Medical was founded by Jacques Seguin.
Who are ReCor Medical's investors?
ReCor Medical's investors include 415 Capital, Sofinnova Partners.
How much funding has ReCor Medical raised?
ReCor Medical has disclosed $22M raised across 1 round.
Where is ReCor Medical headquartered?
ReCor Medical is headquartered in Palo Alto, US.